These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31866076)

  • 21. Relapse rates following antipsychotic discontinuation in the maintenance phase after first-episode of schizophrenia: Results of a long-term follow-up study.
    Üçok A; Kara İA
    Schizophr Res; 2020 Nov; 225():31-38. PubMed ID: 31653578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine.
    Crespo-Facorro B; Pérez-Iglesias R; Mata I; Caseiro O; Martínez-Garcia O; Pardo G; Ramirez-Bonilla M; Pelayo-Terán JM; Vázquez-Barquero JL
    J Psychiatr Res; 2011 Jun; 45(6):763-9. PubMed ID: 21106207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients.
    Gleeson JF; Cotton SM; Alvarez-Jimenez M; Wade D; Gee D; Crisp K; Pearce T; Newman B; Spiliotacopoulos D; Castle D; McGorry PD
    J Clin Psychiatry; 2009 Apr; 70(4):477-86. PubMed ID: 19323964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for Discontinuation of Antipsychotics in Patients Who Recover From First-Episode Schizophrenia Spectrum Disorders: Derived From the Aggregated Opinions of Asian Network of Early Psychosis Experts and Literature Review.
    Asian Network of Early Psychosis Writing Group
    Int J Neuropsychopharmacol; 2022 Sep; 25(9):737-758. PubMed ID: 35451023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 3-year retrospective cohort study of predictors of relapse in first-episode psychosis in Hong Kong.
    Hui CL; Tang JY; Leung CM; Wong GH; Chang WC; Chan SK; Lee EH; Chen EY
    Aust N Z J Psychiatry; 2013 Aug; 47(8):746-53. PubMed ID: 23612934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic consequences of alternative medication strategies in first episode non-affective psychosis.
    Stant AD; TenVergert EM; Wunderink L; Nienhuis FJ; Wiersma D
    Eur Psychiatry; 2007 Sep; 22(6):347-53. PubMed ID: 17418538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
    Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
    Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Research on maintenance treatment to prevent relapse of psychotic disorders.
    Hui CL
    Psychiatry Res; 2022 Nov; 317():114928. PubMed ID: 37732867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perceptions of relapse risks following first-episode psychosis and attitudes towards maintenance medication: a comparison between nursing and social work professionals.
    Chan KK; Chin QP; Tang JY; Longenecker J; Hui CL; Chiu CP; Lam MM; Wong GH; Chen EY
    Early Interv Psychiatry; 2011 Nov; 5(4):324-34. PubMed ID: 21521490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication.
    Di Capite S; Upthegrove R; Mallikarjun P
    Early Interv Psychiatry; 2018 Oct; 12(5):893-899. PubMed ID: 27734591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review.
    Karson C; Duffy RA; Eramo A; Nylander AG; Offord SJ
    Neuropsychiatr Dis Treat; 2016; 12():57-67. PubMed ID: 26792993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates and predictors of relapse in first-episode non-affective psychosis: a 3-year longitudinal study in a specialized intervention program (PAFIP).
    Pelayo-Terán JM; Gajardo Galán VG; de la Ortiz-García de la Foz V; Martínez-García O; Tabarés-Seisdedos R; Crespo-Facorro B; Ayesa-Arriola R
    Eur Arch Psychiatry Clin Neurosci; 2017 Jun; 267(4):315-323. PubMed ID: 27796500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Duration of untreated psychosis: A state-of-the-art review and critical analysis].
    Souaiby L; Gaillard R; Krebs MO
    Encephale; 2016 Aug; 42(4):361-6. PubMed ID: 27161262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis.
    Rubio JM; Schoretsanitis G; John M; Tiihonen J; Taipale H; Guinart D; Malhotra AK; Correll CU; Kane JM
    Lancet Psychiatry; 2020 Sep; 7(9):749-761. PubMed ID: 32828165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting first-episode psychosis patients who will never relapse over 10 years.
    Hui CL; Honer WG; Lee EH; Chang WC; Chan SK; Chen ES; Pang EP; Lui SS; Chung DW; Yeung WS; Ng RM; Lo WT; Jones PB; Sham P; Chen EY
    Psychol Med; 2019 Oct; 49(13):2206-2214. PubMed ID: 30375301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Psychopharmacology of First Episode Psychosis: An Approach Based on Recovery].
    Béchard L; Corbeil O; Malenfant E; Lehoux C; Stip E; Roy MA; Demers MF
    Sante Ment Que; 2021; 46(2):113-137. PubMed ID: 35617496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms.
    Veru F; Jordan G; Joober R; Malla A; Iyer S
    Schizophr Res; 2016 Jul; 174(1-3):183-188. PubMed ID: 27102425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does treatment delay in first-episode psychosis really matter?
    Harrigan SM; McGorry PD; Krstev H
    Psychol Med; 2003 Jan; 33(1):97-110. PubMed ID: 12537041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
    Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.